The Journal of Immunology, Vol 157, Issue 2 806-814, Copyright © 1996 by American Association of Immunologists

ARTICLES

Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni

D Jankovic, L Aslund, IP Oswald, P Caspar, C Champion, E Pearce, JE Coligan, M Strand, A Sher and SL James
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

A CD4+ clone (clone B), characterized as Th1 based on its selective production of IFN-gamma and IL-2, was established from C57Bl/6 mice protectively immunized against Schistosoma mansoni by intradermal vaccination with soluble worm Ags, plus bacillus Calmette Guerin. In agreement with previous results demonstrating an IFN-gamma-dependent cell-mediated protective mechanism in this vaccination model, Ag- elicited peritoneal macrophages from syngeneic recipients of this clone were activated to kill schistosome larvae (schistosomula) in vitro. Moreover, recipients of clone B displayed significant resistance against cercarial challenge. By screening a battery of lambda(gt11) clones from an adult worm cDNA library, one recombinant (25B) was identified that stimulated clone B specifically. Analysis of the 25B cDNA insert revealed a nucleotide sequence identical with that of the large subunit of schistosome calpain, a Ca2+-activated neutral proteinase. By expressing the products of PCR subcloning, we identified a 146-amino acid region of the 25B gene containing immunologic activity equivalent to the whole polypeptide. Overlapping peptides spanning this region were synthesized, and a core epitope was identified with the sequence EWKGAWCDGS. Since clone B responds to supernatants from cultured schistosomula, we postulate that the recognition of calpain released by invading larvae and resulting induction of Th1 cytokines accounts for the protection mediated by the adoptively transferred clone. Our findings thus implicate calpain as a target of protective immunity in schistosomes and provide the first example of a candidate vaccine Ag for this parasite identified on the basis of T cell reactivity.

This article has been cited by other articles:

				D. P. McManus and A. Loukas Current Status of Vaccines for Schistosomiasis Clin. Microbiol. Rev., January 1, 2008; 21(1): 225 - 242. [Abstract] [Full Text] [PDF]

				A. Kumar, K. Kumar, R. Korde, S. K. Puri, P. Malhotra, and V. Singh Chauhan Falcipain-1, a Plasmodium falciparum Cysteine Protease with Vaccine Potential Infect. Immun., April 1, 2007; 75(4): 2026 - 2034. [Abstract] [Full Text] [PDF]

				M. C. Kullberg, J. F. Andersen, P. L. Gorelick, P. Caspar, S. Suerbaum, J. G. Fox, A. W. Cheever, D. Jankovic, and A. Sher Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope PNAS, December 23, 2003; 100(26): 15830 - 15835. [Abstract] [Full Text] [PDF]

				A. A. Siddiqui, T. Phillips, H. Charest, R. B. Podesta, M. L. Quinlin, J. R. Pinkston, J. D. Lloyd, M. Paz, R. M. Villalovos, and J. Pompa Induction of Protective Immunity against Schistosoma mansoni via DNA Priming and Boosting with the Large Subunit of Calpain (Sm-p80): Adjuvant Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-4 Infect. Immun., July 1, 2003; 71(7): 3844 - 3851. [Abstract] [Full Text] [PDF]

				R. Zhang, A. Yoshida, T. Kumagai, H. Kawaguchi, H. Maruyama, T. Suzuki, M. Itoh, M. El-Malky, and N. Ohta Vaccination with Calpain Induces a Th1-Biased Protective Immune Response against Schistosoma japonicum Infect. Immun., January 1, 2001; 69(1): 386 - 391. [Abstract] [Full Text] [PDF]

				D.-H. Yun, J.-Y. Chung, Y.-B. Chung, Y.-Y. Bahk, S.-Y. Kang, Y. Kong, and S.-Y. Cho Structural and Immunological Characteristics of a 28-Kilodalton Cruzipain-Like Cysteine Protease of Paragonimus westermani Expressed in the Definitive Host Stage Clin. Vaccine Immunol., November 1, 2000; 7(6): 932 - 939. [Abstract] [Full Text] [PDF]

				M. T. Brady, S. M. O'Neill, J. P. Dalton, and K. H. G. Mills Fasciola hepatica Suppresses a Protective Th1 Response against Bordetella pertussis Infect. Immun., October 1, 1999; 67(10): 5372 - 5378. [Abstract] [Full Text] [PDF]

				M. Eberl, A. P. Mountford, D. Jankovic, and E. Beck Isolation of T-Cell Antigens by Using a Recombinant Protein Library and Its Application to the Identification of Novel Vaccine Candidates against Schistosomiasis Infect. Immun., July 1, 1999; 67(7): 3383 - 3389. [Abstract] [Full Text] [PDF]

				R. Tarrab-Hazdai, D. Schechtman, and R. Arnon Synthesis and Characterization of a Protective Peptide-Based Vaccine against Schistosoma mansoni Infect. Immun., September 1, 1998; 66(9): 4526 - 4530. [Abstract] [Full Text] [PDF]

				D. J. Campbell and N. Shastri Bacterial Surface Proteins Recognized by CD4+ T Cells During Murine Infection with Listeria monocytogenes J. Immunol., September 1, 1998; 161(5): 2339 - 2347. [Abstract] [Full Text] [PDF]